Pharmacovigilance Asia 2011

Building a harmonised pharmacovigilance framework

Following the very successful Pharmacovigilance Asia conference, PharmaIQ continues the cutting-edge research into the pharmacovigilance field, particularly into the massive and unique market of China.

Pharmacovigilance Asia 2011 is an unique learning platform that will bring together regulators as well as practitioners from the industry to discuss the ongoing pressing issues faced in drug safety, risk management, timeline constraints and varied regulatory standards. A featured panel of experts from the US and Europe will also be invited to provide you with key learning opportunities.

Key Benefits for Attending Pharmacovigilance Asia 2011
• Join the one and only conference platform for both pharmacovigliance regulators and industry practitioners
• Hear from an excellent panel of mixed speakers from both Asia and developed countries including the US and Europe
• Learn about pharmacovigilance and drug safety in Asia today, as well as the challenges and implications ahead to clinical trials and marketing
• Discuss best practices for both post-market and clinical stage pharmacovigilance
• Analyse different processes and methods for ADR case evaluation
• Exploring ways of developing and reinforcing a harmanised pharmacovigilance framework